Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Dec;65(1):e15603.
doi: 10.1111/ped.15603.

Methylprednisolone use in children with severe pneumonia caused by severe acute respiratory syndrome coronavirus 2

Yasemin Ozsurekci  1 , Kubra Aykac  1 , Osman Oguz Demir  2 , Sare Ilbay  1 , Selman Kesici  3 , Jale Karakaya  4 , Ali Bulent Cengiz  1
Affiliations

Methylprednisolone use in children with severe pneumonia caused by severe acute respiratory syndrome coronavirus 2

Yasemin Ozsurekci et al. Pediatr Int. 2023 Jan-Dec.

Abstract

Background: This study aimed to evaluate the effectiveness and optimal use of corticosteroids in children with severe coronavirus disease 2019 (COVID-19) pneumonia, for which effective treatment is still lacking with respect to this population.

Methods: We conducted a retrospective study and included patients (aged < 18 years) with severe COVID-19 pneumonia and/or acute respiratory distress syndrome (ARDS) who received standard doses (2-4 mg/kg/day) and high doses (>250 mg/day) of methylprednisolone (MPZ). We adjusted for patients on steroid treatments with a propensity score and compared the side effects of different MPZ doses and patient survival.

Results: Fifty-nine patients were included: 61% were male, the median age was 8, interquartile range (IQR) 2-15) years. The overall survival was 84.4% in patients treated with standard-dose MPZ (n = 45, 76.3%) and 92.2% in patients treated with high-dose MPZ (n = 14, 23.7%; p = 0.67). The demographic, clinical, and laboratory data did not differ significantly after propensity score matching, apart from bradycardia, which was a prominent feature of the high-dose group. The clinical and radiological response rates on day 7 were higher and the need for invasive mechanical ventilation (IMV) was lower in the high-dose group.

Conclusion: The patients with high-dose MPZ had better clinical and radiological responses than those with standard-dose MPZ, although the mortality rate did not differ between standard and high-dose regimens of MPZ.

Keywords: acute respiratory distress syndrome (ARDS); childhood; coronavirus disease 2019 (COVID-19); corticosteroid; interleukin-1 receptor antagonist.

PubMed Disclaimer

References

REFERENCES

    1. Jimenez-García R, Nogueira J, Retuerta-Oliva A, Sainz T, Cano-Fernández J, Flores-Pérez P, et al. Pneumonia in hospitalized children during SARS-CoV-2 pandemic. Is it all COVID-19? Comparison between COVID and non-COVID pneumonia. Pediatr Infect Dis J. 2021;40(3):e111-e113.
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
    1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
    1. RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693-704.
    1. Cura Yayla BC, Özsürekçi Y, Aykaç K, Derin Oygar P, Laçinel Gürlevik S, İlbay S, et al. Characteristics and Management of Children with COVID-19 in Turkey. Balkan Med J. 2020;37(6):341-7.

Substances

LinkOut - more resources